MiNK Therapeutics financial statements

밍크 테라퓨틱스NASDAQ:INKT · Nasdaq · Healthcare · sector #17
$11.42-2.39%
2026-10-07 close

MiNK Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$11M.

Reported results

MiNK Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy